These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14063725)

  • 21. Twenty-five years with Cryptococcus neoformans.
    Bulmer GS
    Mycopathologia; 1990 Feb; 109(2):111-22. PubMed ID: 2183062
    [No Abstract]   [Full Text] [Related]  

  • 22. The Southeastern Asian house mouse (Mus musculus castaneus Linn.) as a new passenger host for Cryptococcus neoformans var. grubii molecular type VNI.
    Singh K; Rani J; Neelabh ; Rai GK; Singh M
    Med Mycol; 2017 Nov; 55(8):820-827. PubMed ID: 28204573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of cryptococcosis: I. Environmental distribution of cryptococci in Oklahoma.
    Felton FG; Muchmore HG; McCarty MA
    Health Lab Sci; 1974 Jul; 11(3):201-4. PubMed ID: 4600686
    [No Abstract]   [Full Text] [Related]  

  • 24. Virulence and growth rates of Cryptococcus neoformans in mice.
    HASENCLEVER HF; MITCHELL WO
    Ann N Y Acad Sci; 1960 Aug; 89():156-62. PubMed ID: 13712109
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of degree of encapsulation upon virulence of Cryptococcus neoformans.
    LITTMAN ML; TSUBURA E
    Proc Soc Exp Biol Med; 1959; 101():773-7. PubMed ID: 14417558
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.
    Mor V; Farnoud AM; Singh A; Rella A; Tanno H; Ishii K; Kawakami K; Sato T; Del Poeta M
    PLoS One; 2016; 11(4):e0153853. PubMed ID: 27082428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and etiologic significance of Cryptococcus neoformans in a cutaneous lesion of a cat.
    Pal M; Mehrotra BS
    Mykosen; 1983 Dec; 26(12):608-10. PubMed ID: 6363919
    [No Abstract]   [Full Text] [Related]  

  • 29. OCCURRENCE OF CRYPTOCOCCUS NEOFORMANS IN SWEDEN.
    BERGMAN F
    Acta Med Scand; 1963 Nov; 174():651-5. PubMed ID: 14082562
    [No Abstract]   [Full Text] [Related]  

  • 30. [Formation of mucoid capsules in vitro by Cryptococcus neoformans].
    Listemann H
    Mykosen; 1986 Dec; 29(12):556-8. PubMed ID: 3547122
    [No Abstract]   [Full Text] [Related]  

  • 31. [Contributions to the strain-specific virulence of Cryptococcus neoformans. Animal experiments with two C. neoformans-strains isolated from bird manure. Preliminary report (author's transl)].
    Staib F; Mishra SK
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):81-5. PubMed ID: 1101575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe.
    Cogliati M; Puccianti E; Montagna MT; De Donno A; Susever S; Ergin C; Velegraki A; Ellabib MS; Nardoni S; Macci C; Trovato L; Dipineto L; Rickerts V; Akcaglar S; Mlinaric-Missoni E; Bertout S; Vencà ACF; Sampaio AC; Criseo G; Ranque S; Çerikçioğlu N; Marchese A; Vezzulli L; Ilkit M; Desnos-Ollivier M; Pasquale V; Polacheck I; Scopa A; Meyer W; Ferreira-Paim K; Hagen F; Boekhout T; Dromer F; Varma A; Kwon-Chung KJ; Inácio J; Colom MF
    Environ Microbiol; 2017 Oct; 19(10):4318-4325. PubMed ID: 28892309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection methods of cryptococcus neoformans in cryptococcal infection (author's transl)].
    Naruse J; Tamura K; Aoki T; Hayashi Y
    Rinsho Byori; 1974 May; 22(5):373-6. PubMed ID: 4607901
    [No Abstract]   [Full Text] [Related]  

  • 34. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
    Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
    Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of Cryptococcus neoformans from houses of AIDS-associated cryptococcosis patients in Bujumbura (Burundi).
    Swinne D; Deppner M; Laroche R; Floch JJ; Kadende P
    AIDS; 1989 Jun; 3(6):389-90. PubMed ID: 2502153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION.
    BENNETT JE; HASENCLEVER HF
    J Immunol; 1965 Jun; 94():916-20. PubMed ID: 14321434
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis.
    Barchiesi F; Cogliati M; Esposto MC; Spreghini E; Schimizzi AM; Wickes BL; Scalise G; Viviani MA
    J Infect; 2005 Jul; 51(1):10-6. PubMed ID: 15979484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfection.
    Nielsen K; Cox GM; Litvintseva AP; Mylonakis E; Malliaris SD; Benjamin DK; Giles SS; Mitchell TG; Casadevall A; Perfect JR; Heitman J
    Infect Immun; 2005 Aug; 73(8):4922-33. PubMed ID: 16041006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of Cryptococcus neoformans in dry droppings of captive birds in Santiago, Chile.
    González-Hein G; González-Hein J; Díaz Jarabrán MC
    J Avian Med Surg; 2010 Sep; 24(3):227-36. PubMed ID: 21046943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYTOLOGICAL STRUCTURE OF CRYPTOCOCCUS NEOFORMANS.
    TSUKAHARA T
    Jpn J Microbiol; 1963 Aug; 7():53-60. PubMed ID: 14095979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.